Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Urban

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Analytical and Bioanalytical Chemistry|July 6, 2015
Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na(+)-taurocholate cotransporting polypeptide inhibitorMathias Haag, Ute Hofmann, Thomas E Mürdter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2002
Infection of a human hepatoma cell line by hepatitis B virusPhilippe Gripon, Sylvie Rumin, Stephan Urban, et al.
JHEP Reports : Innovation in Hepatology|July 28, 2022
Mitosis of hepatitis B virus-infected cells <i>in vitro</i> results in uninfected daughter cellsThomas Tu, Benno Zehnder, Jochen M Wettengel, et al.
Hepatology (Baltimore, Md.)|February 15, 2017
Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytesFlorian A Lempp, Ellen Wiedtke, Bingqian Qu, et al.
Ebiomedicine|August 29, 2016
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B InfectionCarolin Cornelius, Katrin Schöneweis, Fanny Georgi, et al.
Journal of Hepatology|December 4, 2013
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptorShirin Nkongolo, Yi Ni, Florian A Lempp, et al.
Journal of Virology|March 5, 2025
Identification of NTCP animal orthologs supporting hepatitis B virus binding and infectionFuwang Chen, Jochen M Wettengel, Florian Gegenfurtner, et al.
JHEP Reports : Innovation in Hepatology|September 20, 2022
Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigenBingqian Qu, Firat Nebioglu, Mila M Leuthold, et al.
Viruses|June 4, 2020
Hepatitis B Virus DNA is a Substrate for the cGAS/STING Pathway but is not Sensed in Infected HepatocytesLise Lauterbach-Rivière, Maïwenn Bergez, Saskia Mönch, et al.
Frontiers in Pharmacology|April 24, 2023
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteersVanessa Zhu, Jürgen Burhenne, Johanna Weiss, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Analytical and Bioanalytical Chemistry|July 6, 2015
Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na(+)-taurocholate cotransporting polypeptide inhibitorMathias Haag, Ute Hofmann, Thomas E Mürdter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2002
Infection of a human hepatoma cell line by hepatitis B virusPhilippe Gripon, Sylvie Rumin, Stephan Urban, et al.
JHEP Reports : Innovation in Hepatology|July 28, 2022
Mitosis of hepatitis B virus-infected cells <i>in vitro</i> results in uninfected daughter cellsThomas Tu, Benno Zehnder, Jochen M Wettengel, et al.
Hepatology (Baltimore, Md.)|February 15, 2017
Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytesFlorian A Lempp, Ellen Wiedtke, Bingqian Qu, et al.
Ebiomedicine|August 29, 2016
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B InfectionCarolin Cornelius, Katrin Schöneweis, Fanny Georgi, et al.
Journal of Hepatology|December 4, 2013
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptorShirin Nkongolo, Yi Ni, Florian A Lempp, et al.
Journal of Virology|March 5, 2025
Identification of NTCP animal orthologs supporting hepatitis B virus binding and infectionFuwang Chen, Jochen M Wettengel, Florian Gegenfurtner, et al.
JHEP Reports : Innovation in Hepatology|September 20, 2022
Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigenBingqian Qu, Firat Nebioglu, Mila M Leuthold, et al.
Viruses|June 4, 2020
Hepatitis B Virus DNA is a Substrate for the cGAS/STING Pathway but is not Sensed in Infected HepatocytesLise Lauterbach-Rivière, Maïwenn Bergez, Saskia Mönch, et al.
Frontiers in Pharmacology|April 24, 2023
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteersVanessa Zhu, Jürgen Burhenne, Johanna Weiss, et al.
Pageof 14